Diagnosis and Initiation of Treatment in Parkinson's Disease
Authors:
- Kelly E. LyonsKLKelly E. Lyons
- Rajesh PahwaRPRajesh Pahwa
- 30 September 2011
- journal article
- review article
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 121 (sup2) , 27-36
Abstract
Parkinson's disease (PD) is the most common cause of parkinsonism, yet the diagnosis and management can be a challenge. The United Kingdom Parkinson's Disease Society Brain Bank Clinical Diagnostic Criteria and dopamine transporter/single-photon emission computed tomography (DaT-SPECT) are diagnostic aids that can improve diagnostic accuracy. Even though PD is a progressive disease, for years, physicians and patients have delayed treatment until functional disability occurs. However, studies of monoamine oxidase-type B (MAO-B) inhibitors, dopamine agonists, and levodopa, all of which can be used as initial therapy, have demonstrated that PD patients receiving treatment do better than those who do not receive treatment, and some studies have shown that those receiving treatment earlier do better long term. Therefore, the management strategy for PD has moved toward earlier initiation of treatment. Although treatment for each patient should be individualized and based on their specific symptoms, severity, and lifestyle, in general MAO-B inhibitors may be used initially to treat mild symptoms, adding a dopamine agonist in younger patients or levodopa in older patients, as symptoms become more severe.Keywords
This publication has 35 references indexed in Scilit:
- (123I) β-CIT and Single-Photon Emission Computed Tomographic Imaging vs Clinical Evaluation in Parkinsonian SyndromeArchives of Neurology, 2004
- Reversible parkinsonism with normal β-CIT-SPECT in patients exposed to sodium valproateNeurology, 2004
- Neuroimaging in Parkinson’s diseaseNeuroRX, 2004
- Dopamine Transporter Binding Study in Differentiating Carbon Disulfide Induced Parkinsonism from Idiopathic ParkinsonismNeuroToxicology, 2004
- Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observationsMovement Disorders, 2003
- How valid is the clinical diagnosis of Parkinson's disease in the community?Journal of Neurology, Neurosurgery & Psychiatry, 2002
- Nonmotor fluctuations in Parkinson’s diseaseNeurology, 2002
- Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [123I]-FP-CIT study groupMovement Disorders, 2000
- Accuracy of diagnosis in patients with presumed Parkinson's diseaseAge and Ageing, 1999
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992